A Multi-Component Cognitive-Behavioral Intervention For Sleep Disturbance in Veterans With PTSD - A Pilot Study
A Multi-Component Cognitive-Behavioral Intervention For Sleep Disturbance in Veterans With PTSD - A Pilot Study
A Multi-Component Cognitive-Behavioral Intervention For Sleep Disturbance in Veterans With PTSD - A Pilot Study
Study Objectives: A significant portion of US military person- treatment effect sizes for all sleep diary outcomes, and very
nel are returning from deployment with trauma-related sleep large treatment effects for insomnia severity, sleep quality, and
disturbance, and disrupted sleep has been proposed as a PTSD symptoms.
S C I E N T I F I C I N V E S T I G AT I O N S
mechanism for the development of medical conditions in those Conclusions: Findings demonstrate that an intervention tar-
with posttraumatic stress disorder (PTSD). Although individu- geting trauma-specific sleep disturbance produces large short-
als with PTSD may realize improved sleep with either PTSD term effects, including substantial reductions in PTSD symp-
treatment or CBT for insomnia, many continue to experience toms and insomnia severity. Future research should focus on
residual sleep difficulties. Newly developed interventions de- the optimal approach to the treatment of comorbid PTSD and
signed to address nightmares are effective to this end, but sleep disturbance in terms of sequencing, and should assure
often do not fully remove all aspects of PTSD-related sleep that sleep-focused interventions are available and acceptable
difficulties when used in isolation. A combined intervention in- to our younger veterans, who were more likely to drop out of
volving both a nightmare-specific intervention and CBT for in- treatment.
somnia may lead to more marked reductions in PTSD-related Keywords: PTSD, insomnia, nightmares, imagery rehearsal
sleep disturbances. therapy, nightmare rescripting, cognitive-behavioral therapy for
Methods: Twenty-two veterans meeting criteria for PTSD insomnia, exposure, sleep quality
were enrolled in the study. A combined intervention comprised Citation: Ulmer CS; Edinger JD; Calhoun PS. A multi-com-
of CBT for insomnia and imagery rehearsal therapy was evalu- ponent cognitive-behavioral intervention for sleep distur-
ated against a usual care comparison group. bance in veterans with PTSD: a pilot study. J Clin Sleep Med
Results: Intent-to-treat analyses revealed medium to large 2011;7(1):57-68.
Figure 1—Study participant flow chart Table 1—Baseline demographic and treatment characteristics
Difference
91 Phone Screened Usual Statistics
SIP Care F p
Age 47.00 50.22 0.42 0.53
54 Excluded (Mean Years39) (9.47) (11.62)
35 OSA symptoms reported Time since Trauma 12.51 20.22 1.00 0.33
7 Initial phone contact only (Mean Years 39) (14.47) (16.95)
4 Could not commit to required study appointments
χ2 p
3 Unstable living environment
3 No PTSD symptoms endorsed Gender (% Male) 66.7 55.6 0.23 0.63
1 Lived too far away Race 0.00 1.00
1 Not a Veteran % African American 33.3 33.3
% Caucasian 33.3 33.3
% Other 33.3 33.3
37 Office Screened Working? (% Yes) 33.3 67.7 2.00 0.16
Era of Service 3.72 0.29
% Vietnam Era 11.1 22.2
15 Excluded % Post-Vietnam Era 22.2 11.1
4 Withdrawal prior to baseline completion % Persian Gulf War 22.2 55.6
2 Did not meet diagnostic criteria for PTSD
% OEF/OIF 44.4 11.1
3 Insomnia Severity Index Score ≤ 14
6 Diagnosed with serious mental health condition Antidepressant use 55.6 55.6 0.00 1.00
(% at baseline)
Anxiolytic/hypnotic use 66.7 44.4 0.90 0.34
(% at baseline)
22 Randomized Mental health treatment during 33.3 55.6 0.90 0.34
study (%)
Medication management during 77.8 44.4 2.1 0.15
12 Assigned to 9 Assigned to Wait List study (%)
Intervention Condition Control Condition
9 Completed Follow-Up 9 Completed Follow-Up insomnia), 8-14 (subthreshold insomnia), 15-21 (insomnia of
Assessment Assessment
moderate severity), and 22-28 (severe insomnia). The ISI has
adequate psychometric properties, has been validated against
diary and polysomnographic measures of sleep,25 and has been
Disorders sleep disorder diagnoses.22 The DSISD includes shown sensitive to therapeutic changes in several of our treat-
questions that incorporate criteria for ascertaining sleep dis- ment studies of insomnia. The ISI was used to determine treat-
orders within both the DSM-IV and the recently updated ment eligibility, to assess treatment outcome, and to determine
ICSD sleep disorder nosologies. The instrument has accept- clinical significance of study findings.
able reliability and discriminant validity, and is effective for Electronic Sleep Diary: Subjective sleep estimates were
discerning the types of sleep disorders that would disqualify obtained using a hand-held computer (PDA) containing an
participants for this study. interactive program that automates the collection of subjec-
Folstein Mini-Mental Status Exam: The Folstein Mini- tive sleep data. The PDA device was programmed to elicit
Mental Status Exam (MMSE)23 was administered to all study daily responses from participants and electronically record
candidates using standard administration/scoring procedures. multiple days of subjective sleep information, in addition to
The MMSE was used to identify and exclude individuals who the number and severity of nightmares for the previous night.
have cognitive deficits that would preclude their ability to pro- Five variables of interest were calculated or obtained from
vide informed consent or to fully participate in an interactive electronic sleep diaries, as follows: total sleep time (TST);
treatment process. As consistent with clinical applications for sleep onset latency (SOL); wake after sleep onset (WASO);
dementia screening, those with a score < 24 were excluded sleep efficiency % (SE); and nightmare frequency (NM fre-
from the study. quency).
Insomnia Severity Index (ISI): The ISI24 is a 7-item ques- The Pittsburgh Sleep Quality Index (PSQI): The PSQI26 is a
tionnaire that provides a global measure of perceived insom- self-rating scale that yields a quantitative index of general sleep
nia severity. Each item is rated on a 5-point Likert scale, and quality/disturbances. The PSQI is composed of 4 open-ended
the total score ranges from 0-28. The following guidelines are questions and 19 self-rated items (0-3 scale) assessing sleep
recommended for interpreting the total score: 0-7 (no clinical quality and disturbances over a 1-month interval, and yields a
Table 4—Comparison of predicted means, standard error (SE) values and treatment effect sizes for intent-to-treat groups on
sleep diary outcomes
Measure Baseline Post-Intervention Predicted Difference Statistic Effect Size
SIP Group TAU Group F Cohen’ s d
TST (Hours) M 5.23 6.47 5.26
6.33* 1.06
SE 0.24 0.37 0.35
WASO (Minutes) M 92.75 42.03 88.00
5.91* -0.90
SE 10.87 14.47 13.73
SOL (Minutes) M 50.40 22.39 45.03
10.17** -0.66
SE 7.30 6.55 6.32
SE (Percentage) M 68.86 86.89 70.91
14.61** 1.27
SE 2.68 3.24 3.07
NM Frequency M 0.67 0.51 0.83
5.03* -0.60
(Mean per Night) SE 0.11 0.18 0.17
Table 5—Comparison of means, standard error (SE) values and treatment effect sizes for participants with complete baseline
and post-intervention data on sleep log outcomes
Measure Baseline Post-Intervention ANOVA Statistics
SIP TAU GROUP (A) TIME (B) A×B A×B
Sleep Log Variable N=8 N=9 F F F Cohen’s d
TST (Hours) M 5.27 6.56 5.24
2.11 4.08 3.54 1.06
SE 0.29 0.46 0.35
WASO (Minutes) M 88.93 30.95 92.58
8.54* 4.31* 1.14 -1.37
SE 10.58 7.34 18.28
SOL (Minutes) M 42.95 12.45 45.11
6.52* 8.17* 2.68 -1.30
SE 5.93 2.11 8.92
SE (Percentage) M 69.98 89.58 69.92
8.51* 9.99** 3.70 1.48
SE 3.12 2.06 4.24
NM Frequency M 0.63 0.27 0.73
0.95 0.15 4.96* -0.89
(Mean per Night) SE 0.53 0.26 0.94
Table 6—Comparison of predicted means, standard error (SE) values, and treatment effect sizes for intent-to-treat groups on
questionnaire outcomes
Measure Baseline Post-Intervention Predicted Difference Statistic Effect Size
SIP Group TAU Group F Cohen’s d
ISI M 22.46 12.45 21.58
11.80** -2.15
SE 0.91 1.90 1.90
PCL-M M 63.23 45.25 66.08
22.72** -1.76
SE 2.53 3.51 3.51
PHQ M 3.81 3.45 4.06
0.86 -0.34
SE 0.39 0.54 0.54
PSQI M 14.24 9.31 14.47
17.31** -1.60
SE 0.70 1.07 1.07
PSQI-A M 10.00 7.74 9.11
0.76 -0.30
SE 0.96 1.36 1.36
Table 7—Comparison of means, standard error (SE) values and treatment effect sizes for participants with complete baseline
and post-intervention data on outcome questionnaires
Measure Baseline Post-Intervention ANOVA Statistics
SIP TAU GROUP (A) TIME (B) A×B A×B
Questionnaires N=9 N=9 F F F Cohen’s d
ISI M 22.22 12.44 21.44
5.23* 12.34** 9.88** -2.17
SE 0.98 2.43 1.25
PCL-M M 62.39 44.00 66.22
5.29* 9.24** 17.63** -1.85
SE 2.83 4.99 2.99
PHQ M 3.61 3.11 4.11
0.93 0.00 0.38 -0.55
SE 0.43 0.72 0.54
PSQI M 13.67 8.22 14.56
6.47* 13.21** 15.91** -2.05
SE 0.73 1.41 1.09
PSQI-A M 9.28 6.56 9.11
0.93 3.18 0.47 -0.58
SE 1.04 1.54 1.76
tion. Groups did not differ significantly in depression (PHQ) the intervention group participants (4/4 or 100%) in this sub-
or trauma-related sleep quality (PSQI-A) change from baseline sample had achieved “normal” SOL as compared to only 14%
to post-intervention. Effect sizes for all significant completers- of usual care participants (1/7) (χ2 = 7.5, p = 0.02). Groups did
only questionnaire outcomes fell in the “very large” (> 1.50) not differ at post-intervention on the percentage of WASO re-
range, and in the “moderate” range for nonsignificant question- mitters (χ2 = 0.79, p = 0.55), with 1 of 9 remitting in the wait list
naire outcomes. group and 2 of 7 in the intervention group.
80
Score
60
40
20
0
10 15 17 39 48 49 50 83 87 4 9 19 24 25 76 82 84
Participant #
150
Score
100
50
0
10 15 17 39 48 49 50 83 87 4 9 19 24 25 76 82 84
Participant #
30
25
20
Score
15
10
0
10 15 17 39 48 49 50 83 87 4 9 19 24 25 76 82 84 88
Participant #
PCL-M BL
PCL-M POST
Wait List Control Sleep Intervention for PTSD
90
80
70
60
50
Score
40
30
20
10
0
10 15 17 39 48 49 50 83 87 4 9 19 24 25 76 82 84 88
Participant #
20
15
Score
10
0
10 15 17 39 48 49 50 83 87 4 9 19 24 25 76 82 84 88
Participant #
sleep quality, groups did not differ at post-intervention on the tion to usual care in terms of differential symptoms of sleep
percentage of sleep quality remitters, with 3 (3/9 or 33.3%) of disturbance at post-intervention. We hypothesized that this
those in the intervention group remitting, and none of those combined intervention, in addition to usual care, would pro-
in the usual care group (0/9 or 0%). Finally, with regard to duce better outcomes than usual care alone. Our hypothesis
PTSD-specific disruptive nocturnal behaviors, groups did not was supported in terms of both average improvement across
differ at post-intervention with 3 (3/9 or 33.3%) of those in individual measures and the clinical significance of our find-
the intervention group remitting and one (1/9 or 11.1%) in the ings. Intent-to-treat analyses revealed medium to large effect
usual care group (χ2 = 1.29, p = 0.26). sizes (group differences) for all sleep diary outcomes, and very
large treatment effects (Cohen’s d > 1.50) for insomnia sever-
DISCUSSION ity, sleep quality, and PTSD symptoms. In contrast, none of the
participants in the usual care group responded or remitted from
The primary purpose of our study was to assess the feasibil- insomnia or PTSD, and did not improve from baseline on sleep
ity of SIP using a randomized trial design. Although the study quality. SIP did not produce a treatment effect for depression,
revealed the need for slight procedural changes to be incorpo- and although SIP is not designed to treat depression, this find-
rated into a larger trial, the overall findings suggest that the in- ing was surprising in light of the treatment effect on correlated
tervention is feasible and generally acceptable to veterans with issues: insomnia and PTSD. We suspect that the failure to find a
PTSD. Our secondary purpose was to compare the interven- significant effect for depression may be related to the restricted